AFT · AFT Pharmaceuticals Ltd.
4.27
NZDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
NZ$419.50M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
18%
MQV Rating
1Very Strong
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Extreme Overbought
- HALO 100
- HALO All
- HALO Dividend Growth
- HALO Momentum
- HALO MQV
- HALO MQV SMALL
- HALO Price Momentum
- HALO Small
- Near 52 Week High
- Near Resistance
- Volume Spike
Key Fundamentals
EPS 3 yr Growth
-5.90%
EBITDA Margin
11.00%
Operating Cashflow
-$12m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
Low 2.54 - 4.28
Trade Value (12mth)
US$9,040.00
1 week
9.21%
1 month
16.35%
YTD
26.33%
1 year
55.27%
All time high
5.65
Additional Data
Shares Outstanding (Fully Diluted)
105m
HALO Sector
Healthcare
Next Company Report Date
24-May-27
Next Ex Dividend Date
18-Jun-26
Next Dividend Pay Date
03-Jul-26
Reporting Currency
NZD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Strong
Garp
Strong
Mqv Small
Very Strong
Momentum
Price
Very Strong
Earnings
Strong
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Strong
Valuation
News & Announcements
No announcements available.